We performed a proof-of-concept study showing that single-cell RNA sequencing, a method for capturing rich tumor information (not yet in clinics owing to high costs), can be used to identify patients likely to respond to targeted therapy and to monitor the emergence of resistance.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Cohen, Y. C. et al. Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing. Nat. Med. 27, 491–503 (2021). This paper was the first to show a method for integrating scRNA-seq into clinical trials of multiple myeloma and find a resistance signature.
Griffiths, J. I. et al. Serial single-cell genomics reveals convergent subclonal evolution of resistance as patients with early-stage breast cancer progress on endocrine plus CDK4/6 therapy. Nat. Cancer 2, 658–671 (2021). This paper used serial single-cell genomics to track individual resistance in patients with early-stage breast cancer.
Maynard, A. et al. Therapy-induced evolution of human lung cancer revealed by single-cell RNA sequencing. Cell 182, 1232–1251 (2020). This paper used single-cell genomics to track how human lung cancer evolves in response to therapy.
Ahmadi, A. et al. The landscape of receptor-mediated precision cancer combination therapy via a single-cell perspective. Nat. Commun. 13, 1613 (2022). This paper reports a computational tool designed to identify optimal combinations of gene targets that maximize cancer cell eradication while minimizing toxicity from the destruction of normal cells.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This is a summary of: Sinha, S. et al. PERCEPTION predicts patient response and resistance to treatment using single-cell transcriptomics of their tumors. Nat. Cancer https://doi.org/10.1038/s43018-024-00756-7 (2024).
Rights and permissions
About this article
Cite this article
Using single-cell transcriptomics to predict which tumors will respond to targeted therapy. Nat Cancer (2024). https://doi.org/10.1038/s43018-024-00757-6
Published:
DOI: https://doi.org/10.1038/s43018-024-00757-6
